Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-24

Clinical Trial Update: Zomig - Treatment of Acute Migraine Headache in Adolescents [Phase 4]

View source ↗

Summary

Phase 4 trial results for Zomig (sumatriptan) in adolescents with acute migraine were completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zomig (Zolmitriptan)

Snippet

Sponsor: AstraZeneca | Conditions: Migraine Headache | Phase 4 | Status: COMPLETED | Results posted: 2014-10-24